If you have ever watched a man make a relatively modest change to his diet and lose visible body fat in three weeks while you have been training consistently for three months and the scale has barely moved, you have experienced one of the more frustrating facts of human biology firsthand. It is not a motivation gap. It is not a discipline gap. It is a physiology gap and it runs considerably deeper than most generic fitness advice acknowledges.
Women and men store fat differently, mobilise it differently, and respond differently to the hormonal, metabolic, and caloric conditions that govern fat loss. ThermoShred Capsules are formulated with the specific metabolic mechanisms relevant to female fat physiology not a generic thermogenic designed around male-default research. Here is the full biological picture of why women's bodies handle fat the way they do, and what actually works as a result.
The biology of why women carry more fat and why that is not the problem
A healthy woman carries roughly 20 to 25 percent body fat. A healthy man of equivalent fitness carries roughly 10 to 15 percent. This is not a question of discipline or diet quality, it is the result of millions of years of evolutionary biology. The female body is calibrated to maintain adequate fat stores for the metabolic demands of pregnancy and lactation, and the hormonal system that governs female reproduction, particularly estrogen, is directly involved in fat storage regulation.
Estrogen activates lipoprotein lipase (LPL) , an enzyme that promotes fat storage in subcutaneous fat depots in the lower body: hips, thighs, gluteal region. This is the classic female fat distribution pattern, the "pear shape" that describes where most premenopausal women accumulate fat preferentially. It is protective in certain contexts subcutaneous fat in the lower body is metabolically less active and less inflammatory than visceral fat but it is also more resistant to mobilisation. The fat stored in these depots during the reproductive years is, from the body's perspective, a strategic reserve. It does not give it up readily.
This is why the lower body fat that women often want to lose most is, physiologically, the hardest to shift. It is not stored there by accident. The body put it there deliberately.
How the menstrual cycle changes metabolism and why no one told you this
The menstrual cycle is not simply a reproductive event. It is a metabolic one. Estrogen and progesterone fluctuate across the roughly 28-day cycle, and those fluctuations have measurable effects on fuel utilisation, appetite, resting metabolic rate, and exercise performance.
In the follicular phase (days one to fourteen, estrogen rising), insulin sensitivity is generally higher, carbohydrate oxidation is more efficient, and the body is in a more anabolic state. Training tends to feel better, recovery is faster, and the metabolic environment is generally more cooperative.
In the luteal phase (days fifteen to twenty-eight, progesterone dominant), resting metabolic rate rises slightly; research suggests 100 to 300 calories per day in some women but so does appetite, and so does the preference for calorie-dense foods. Insulin sensitivity drops moderately. The body shifts toward slightly greater fat oxidation during exercise but also stores more readily. Water retention is higher due to progesterone and aldosterone effects. The scale goes up and most women interpret this as fat gain. It is largely fluid.
The practical implication is that the same diet and training plan will produce different results at different points in the cycle not because effort changed, but because the hormonal environment did. A fat loss strategy that ignores the menstrual cycle is working against the body's own metabolic rhythms rather than with them.
The insulin and cortisol picture that makes female fat loss harder than calorie math suggests
Women's fat cells have a higher density of alpha-2 adrenergic receptors particularly in the lower body compared to men. These receptors respond to catecholamines (adrenaline, noradrenaline) by inhibiting fat release, rather than promoting it. Men's fat cells, by contrast, have a higher ratio of beta-adrenergic receptors, which promote fat mobilisation in response to the same catecholamine signal. This receptor profile is a large part of why male fat mobilises more readily from storage; the same hormonal signal that is supposed to unlock fat for fuel is more likely to lock it in for women.
Cortisol compounds this. Chronic cortisol elevation from inadequate sleep, high stress, underfuelling, or excessive training without recovery promotes visceral fat accumulation in women and actively opposes fat mobilisation from subcutaneous depots. It also elevates insulin, which signals fat storage. The woman who is under-eating, over-training, and chronically stressed is not creating the metabolic conditions for fat loss, she is creating the hormonal conditions for fat retention, regardless of the caloric deficit on paper.
What ThermoShred targets and the mechanisms behind it
Effective metabolic support for women needs to address the specific physiological obstacles to female fat mobilisation: insulin sensitivity, the alpha-2 receptor dominance in lower body fat depots, thermogenesis, and the appetite fluctuations driven by the luteal phase hormonal environment.
Berberine, one of the key actives in ThermoShred is a plant alkaloid with well-documented effects on glucose metabolism and insulin sensitivity. It is thought to activate AMPK (adenosine monophosphate-activated protein kinase), an enzyme sometimes described as the body's metabolic master switch, which enhances glucose uptake into cells, reduces hepatic glucose production, and improves insulin sensitivity. Better insulin sensitivity means lower baseline insulin levels, which creates a more favourable hormonal environment for fat mobilisation particularly relevant in the luteal phase when insulin sensitivity naturally dips.
Green tea extract, standardised for EGCG (epigallocatechin gallate) and caffeine, targets thermogenesis and fat oxidation through a complementary pathway. EGCG inhibits the enzyme catechol-O-methyltransferase (COMT), which normally breaks down noradrenaline. By slowing this breakdown, EGCG extends the fat-mobilising signal partially countering the alpha-2 adrenergic receptor dominance in female lower body fat. The caffeine component amplifies this thermogenic effect and supports the beta-adrenergic activity that promotes fat release.
The combination of improved insulin sensitivity and enhanced thermogenic fat oxidation addresses the two primary physiological obstacles to female fat loss simultaneously.
